The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Key Takeaways From the U.S. CDC’s 2019 Antibiotic Resistance Threats Report for Frontline Providers
Open accessAbstract
Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD The opinions expressed in this article are those of the author and do not represent any position or policy of the National Institutes of Health, the U.S. Department of Health and Human Services, or the U.S. government. Supported, in part, by the intramural research program of the National Institutes of Health Clinical Center. Dr. Kadri received support for article research from the National Institutes of Health, and he disclosed government work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida auris is an emerging multidrug-resistant skin-tropic fungal pathogen that causes serious human infections.”
From The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin (2025) · cites this paper as [3]
In the citing paper
“Candida auris was recently categorized as an urgent threat by the U.S. Centers for Disease Control and Prevention (CDC) and classified in the critical priority fungal pathogen group by the World Health Organization (1 – 3).”
From Differential skin immune responses in mice intradermally infected with Candida auris and Candida albicans (2023) · cites this paper as [3]
In the citing paper
“Candida auris is an emerging multidrug-resistant fungal pathogen that preferentially colonizes and persists in skin tissue”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,877
Stevens, D. L., Bisno, A. L., Chambers, H. F. “., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,870
Logan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,593
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
Bevan, E. R., Jones, A. M., & Hawkey, P. M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx146 · Cited by 831
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yılmaz, M., Alenazi, T. H., Arabi, Y. M., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 789
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809e1 · Cited by 701
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 673
van Duin, D., Lok, J. J., Earley, M. J., Cober, E., Richter, S. S., Pérez, F., Salata, R. A., Kalayjian, R. C., Watkins, R., Doi, Y., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 657
Cited by
Sorted by citations
Rhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., Klompas, M., & Program, F. T. C. P. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2899 · Cited by 397
Self-citationAn Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M. T. D. S., Antunes, W., MOTA, S. R. F., Madureira-Carvalho, Á., Dinis‐Oliveira, R. J., & da Silva, D. D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 349
Taking phototherapeutics from concept to clinical launch
Vickerman, B. M., Zywot, E. M., Tarrant, T. K., & Lawrence, D. S. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00326-w · Cited by 201
Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century
Saha, M. S., & Sarkar, A. (2021) · Journal of Xenobiotics · doi:10.3390/jox11040013 · Cited by 216
Feng, Y., Tonon, C. C., Ashraf, S., & Hasan, T. G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113941 · Cited by 166
Metadata
- Authors
- Kadri, S. S.
- Affiliations
- United States Department of Health and Human Services (US)
- Corresponding author
- Kadri, Sameer S.
- ORCID
- Kadri, Sameer S.
- Venue
- Critical Care Medicine
- Published
- 2020-07
- Volume
- 48
- Issue
- 7
- Pages
- 939-945
- ISSN
- 0090-3493 (ISSN-L)
- PMC
- PMC7176261
- OpenAlex
- W3016146168
- Cited by
- 292
- References
- 45
- Citations by year
- 2026: 36 · 2025: 59 · 2024: 62 · 2023: 65 · 2022: 36 · 2021: 29 · 2020: 4
- FWCI
- 19.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antibiotic resistance, antimicrobial resistance, frontline health workers, clinical practice implications, intensive care
- MeSH terms
- Acinetobacter Infections, Candida, Candidiasis, Centers for Disease Control and Prevention, U.S., Clindamycin, Enterobacteriaceae, Enterobacteriaceae Infections, Humans, Pseudomonas Infections, Streptococcal Infections, United States, Vancomycin Resistance, Drug Resistance, Bacterial, Drug Resistance, Multiple, Bacterial, Drug Resistance, Fungal, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
